Skip to main content

Longeveron Inc.

LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001721484

No open-market purchases or sales by Longeveron Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $3.35M in total; no superinvestor holds it.

Superinvestors holding LGVN, Q2 2026

See all superinvestors

No superinvestor reported holding LGVN in Q2 2026.